Kopran Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,86,208 shares,. Its Average Traded Price (ATP) is ₹262.96, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 150 @ ₹264.40.
Kopran has an upper circuit limit of ₹320.46 and a lower circuit limit of ₹213.64. The total value traded stands at ₹4.90 CR, and the delivery percentage for the day is 42.35%.
The stock is currently traded with a market lot size of 1. Kopran also offers a dividend yield of 1.13%.
Kopran Share Price Chart
Kopran Share Key Metrics
Volume
1.86 L
Market Cap
1270.74 CR
LTQ@LTP
150@264.40
ATP
262.96
Var Margin
24.72 %
Circuit Range
213.64-320.46
Delivery %
42.35 %
Value
4.90 CR
ASM/GSM
No
Market Lot
1
Kopran Resistance and Support
Pivot 267.65
Resistance
First Resistance
271.49
Second Resistance
275.94
Third Resistance
279.78
Support
First Support
263.2
Second Support
259.36
Third Support
254.91
Kopran Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Kopran Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-03 | Quarterly Results |
| 2026-05-19 | Audited Results & Final Dividend |
| 2026-01-22 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-15 | Audited Results & Final Dividend |
| 2024-11-13 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2025-09-04 | 2025-09-04 | View More |
Kopran News
Kopran Ltd - 524280 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter group entity Sarvamangal Mercantile Company Limited acquired 1.70 lakh shares (0.35% stake) of Kopran Limited via market purchase on 29 September 2026. Following this, its total holding increased to 6.36%.
Nov 13 2026 10:19:14
Kopran Ltd - 524280 - Board Meeting Outcome for Result Q2 FY 2026-27
Kopran Ltd reported Q2 FY26 consolidated revenue of ₹211.26 crores, up 79% YoY, and a net profit of ₹4.39 crores, recovering from a net loss of ₹9.92 crores in Q2 FY25. Total expenses for the quarter stood at ₹205.99 crores.
Nov 03 2026 13:40:31
Kopran Ltd - 524280 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Kopran concluded the EU GMP inspection at its Khopoli formulation facility with no critical observations and one major observation. The inspection was conducted from September 18 to September 23, 2026, and the company will submit its responses within a fortnight.
Oct 22 2026 13:01:49
Kopran Management
| Name | Position |
|---|---|
| Sunil Sodhani | Company Secretary & Compliance Officer |
| Susheel G Somani | Chairman |
Kopran Similar Stocks
Jagsonpal Pharmaceuticals Ltd.
209.27
-1.15 (0.55%)
Anlon Healthcare Ltd.
25.17
0.20 (0.80%)
Fermenta Biotech Ltd.
442.50
-19.80 (4.28%)
KMC Speciality Hospitals (India) Ltd.
203.78
2.14 (1.06%)
Shalby Ltd.
121.26
-0.63 (0.52%)
Gujarat Kidney And Super Speciality Ltd.
149.28
-1.27 (0.84%)
Bajaj Healthcare Ltd.
319.90
1.40 (0.44%)
3B Blackbio Dx Ltd.
1319.90
3.30 (0.25%)
Bafna Pharmaceuticals Ltd.
469.95
-9.55 (1.99%)
GPT Healthcare Ltd.
133.81
1.36 (1.03%)
Kopran FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in KOPRAN
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC